Inmune Bio (INMB) Change in Account Payables (2018 - 2025)
Inmune Bio (INMB) has disclosed Change in Account Payables for 8 consecutive years, with $81000.0 as the latest value for Q2 2025.
- Quarterly Change in Account Payables fell 2.41% to $81000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $45000.0 through Jun 2025, down 26.23% year-over-year, with the annual reading at -$10000.0 for FY2024, 138.46% down from the prior year.
- Change in Account Payables hit $81000.0 in Q2 2025 for Inmune Bio, up from $78000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $83000.0 in Q2 2024 to a low of -$84000.0 in Q3 2024.
- Historically, Change in Account Payables has averaged $5714.3 across 5 years, with a median of $0.0 in 2021.
- Biggest five-year swings in Change in Account Payables: tumbled 4500.0% in 2023 and later skyrocketed 271.43% in 2025.
- Year by year, Change in Account Payables stood at $70000.0 in 2021, then crashed by 98.57% to $1000.0 in 2022, then crashed by 4500.0% to -$44000.0 in 2023, then soared by 31.82% to -$30000.0 in 2024, then skyrocketed by 370.0% to $81000.0 in 2025.
- Business Quant data shows Change in Account Payables for INMB at $81000.0 in Q2 2025, $78000.0 in Q1 2025, and -$30000.0 in Q4 2024.